The DOI matches its Crossref record, with a small difference in title or year; 263 of the 263 references it cites were found in a registry or an index.
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Open accessAbstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As such, while all patients with T2DM and CAD certainly benefit from a blood pressure of <140/90 mm Hg,5,63–66,76”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For people who already have diabetes, lifestyle modification and pharmacological treatment, as well as blood pressure and cholesterol control, can delay progression to complications and reduce mortality, or even help with remission, especially if started early.1,2,58–62”
From Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredIn the citing paper
“Epidemiological studies have shown that high levels of LDL-C and non-HDL-C and low levels of HDL-C are associated with an increased risk of CV events and mortality in patients with and without diabetes.246”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [246]
In the citing paper
“The most common causes of death in patients with T2DM and CKD are atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) (6,7).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [7]
In the citing paper
“The presence of hypertension in patients with T2DM significantly increases the risk of myocardial infarction, stroke, and all-cause mortality.63,64”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“The prevalence of hypertension in patients with T2DM is ≈2-fold greater than in the general population, with the vast majority of patients with T2DM (70%–80%) having concomitant hypertension.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Early interventional randomized trials showed benefit of aggressive blood pressure reduction in reducing the increased risk of both macrovascular and microvascular events in patients with T2DM.63”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Epidemiological observations have demonstrated that there is a progressive increase in the risk of macrovascular and microvascular events with increasing levels of systolic blood pressure starting at 115 mm Hg.63–65”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
In the citing paper
“Instead, evidence to support lifestyle and health behavior management for T2DM and stable CAD has been extrapolated from primary prevention trials and from subgroups of participants with T2DM from studies focusing on the secondary prevention of CAD.63,136”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
RetractedToprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Research works printed but not linked: 2
- 10.1161/circ.100.10.1132 · DOI
- Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, de Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Levey AS, Riella MC, Shlipak MG, Wang H, White CT, Winearls CG. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Cited by
Sorted by citations
Items 201–300 of 386
Liu, H., Liu, J., Zhao, H., & Wang, H. (2020) · International Angiology · doi:10.23736/s0392-9590.19.04210-x · Cited by 10
Cao, G., Fan, J., Yu, H., & Chen, Z. (2018) · PubMed Central · Cited by 10
Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
Dong, X., Zhou, W., Li, H., Fan, Y., Yin, X., Li, Y., Chen, F., & Ma, G. (2019) · Clinical Cardiology · doi:10.1002/clc.23243 · Cited by 9
Beigrezaei, S., Yazdanpanah, Z., Soltani, S., Rajaie, S. H., Mohseni‐Takalloo, S., Zohrabi, T., Kaviani, M., Forbes, S. C., Baker, J. S., & Salehi‐Abargouei, A. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01669-7 · Cited by 9
Sinamaw, D., Getnet, M., Abdulkadir, M., Abebaw, K., Ebrahim, M., Diress, M., Akalu, Y., Ambelu, A., & Dagnew, B. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02661-2 · Cited by 9
Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events
Kim, J., & Becker, R. C. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1307-2 · Cited by 9
Yang, C. X., Zhu, C., Guo, Y., Wu, N., Dong, Q., Xu, R., Yongjian, W., Qian, J., & Li, J. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0410 · Cited by 8
de Godoy, E. P., Pereira, S. S. D. S., Coelho, D., MARREIROS, I., da Luz, V. F., Coutinho, J. L., Palitot, T. R. D. C., Costa, H. B. D. F., Campos, J. M., & Brandt, C. T. (2019) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20192264 · Cited by 8
Rabbani, M., Tian, S., Anik, A. A., Luo, J., Park, M. S., Whittle, J., Ahamed, S. I., & Oh, H. (2022) · IEEE Annual International Computer Software and Applications Conference (COMPSAC) · doi:10.1109/compsac54236.2022.00095 · Cited by 9
Mengden, T., Ligges, U., Mielke, J., Bramlage, P., Korzinek, A., & Sehnert, W. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13001 · Cited by 8
Factors Predicting Sodium Intake of Korean Americans with Type 2 Diabetes
Ko, J., Kim, K. B., Timmerman, G. M., Clark, A. P., & Kim, M. T. (2017) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-017-0602-8 · Cited by 8
What Do the Guidelines Really Say About Aspirin?
Millard, M. A., & Hernandez-Vila, E. A. (2018) · Texas Heart Institute Journal · doi:10.14503/thij-18-6673 · Cited by 8
Huang, Y., Gu, L., Li, N., Fang, F., Ding, X., Wang, Y., & Peng, Y. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00653-4 · Cited by 9
Targeting Vascular Risk Factors in Older Adults
Mossello, E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.5941 · Cited by 7
Xu, W., Feng, Y., Abdullah, G., Li, L., Fang, P., Tang, S., Yang, H., Kong, D., Huang, H., Wang, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376463 · Cited by 7
Wang, S., Ma, Z., Zhang, Y., Ding, Y., Chen, Z., & Wang, L. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0905-2 · Cited by 7
Giustino, G., Colantonio, L. D., Brown, T. M., Carson, A. P., Dai, Y., Farkouh, M. E., Monda, K. L., Muntner, P., & Rosenson, R. S. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6816-8 · Cited by 7
Lee, J., Oh, J. S., Zhu, J. H., Hong, S., Park, S. H., Kim, J. H., Kim, H., Seo, M., Kim, K. W., Lee, D. H., et al. (2020) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-020-00782-1 · Cited by 7
Bolat, S., Zararsız, G. E., Doğan, K., Koçhan, N., Yerlitaş, S. İ., Cephe, A., Zararsız, G., & Cicero, A. F. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103570 · Cited by 8
KONES, R. J., & Rumana, U. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1421395 · Cited by 7
Wittbrodt, E. T., Bhalla, N. P., Sundell, K. A., Gao, Q., Dong, L., Cavender, M. A., Hunt, P. R., Wong, N. D., & Mellström, C. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.133 · Cited by 7
Prevention of Type 2 Diabetes through Sardines Consumption: An Integrative Review
Díaz‐Rizzolo, D. A., Miro, A., & Gomis, R. (2021) · Food Reviews International · doi:10.1080/87559129.2020.1867565 · Cited by 7
Aronow, W. S., & Shamliyan, T. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.08.43 · Cited by 7
Amiri, M., Raeisi‐Dehkordi, H., Moghtaderi, F., Zimorovat, A., Mohyadini, M., & Salehi‐Abargouei, A. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02898-9 · Cited by 6
Mohamadi, A., Shiraseb, F., Mirzababaei, A., AkbarySedigh, A., Ghorbani, M., Clark, C. C. T., Aali, Y., & Mirzaei, K. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1169398 · Cited by 8
Hammoudeh, A. J., Tabbalat, R. A., Alhaddad, I. A., Khader, Y. S., Jarrah, M., Izraiq, M., & Al-Mousa, E. N. (2016) · Diabetology International · doi:10.1007/s13340-016-0273-z · Cited by 6
Miao, X., Zhang, W., Huang, Z., & Li, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162405 · Cited by 6
McCarthy, M. M., Wackers, F. J. T., Davey, J. A., & Chyun, D. A. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.05.005 · Cited by 6
Gori, M., Canova, P. A., Calabrese, A., Cioffi, G., Trevisan, R., Maria, R. D., Grosu, A., Iacovoni, A., Fontana, A., Ferrari, P., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.101 · Cited by 6
Kobalava, Z. D., & Kiyakbaev, G. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-8-79-91 · Cited by 7
Stroke among Type 2 Diabetes Mellitus Patients at Haji Adam Malik General Hospital, Medan, Indonesia
Amelia, R., & Harahap, N. S. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.743 · Cited by 6
Jarrah, M., Al-Khatib, S., Khader, Y. S., AlKharabsheh, H. N., Hammoudeh, A. J., Alzoubi, K. H., & Alrabadi, N. (2020) · International Journal of Vascular Medicine · doi:10.1155/2020/7624158 · Cited by 6
Fuentes, B. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.09.012 · Cited by 6
da Silva, A. M. P., Cardoso, L. J. C., Batista, S., Gonçalves, O. R., Paranhos, T., Teixeira, I. P. S., Guimarães, P. D., Franco, B. E., Cal, H. D. S. R., Salles, J. E. N., et al. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109306 · Cited by 5
Diabetes and Stroke—A Focused Review
Menon, B., Syed, R., Yadav, P. K., & Menon, M. P. K. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_46_24 · Cited by 8
Implementation of Cardiometabolic Centers and Training Programs
Taha, M. B., Rao, N., Vaduganathan, M., Cainzos‐Achirica, M., Nasir, K., & Patel, K. V. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01459-y · Cited by 5
Type 2 diabetes - factors of occurrence and its complications
Żuchnik, M., Rybkowska, A., Szczuraszek, P., Szczuraszek, H., Bętkowska, P., Radulski, J., Tomkiewicz, M., Paluch, M., Licak, G., & Olko, P. (2023) · Quality in Sport · doi:10.12775/qs.2023.10.01.003 · Cited by 5
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial
Briguori, C., Madonna, R., Zimarino, M., Calabrò, P., Quintavalle, C., Salomone, M., Condorelli, G., & Caterina, R. D. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6672-3 · Cited by 5
Obesity and Type 2 Diabetes in Our Youth: A Recipe for Cardiovascular Disease
Wooton, A. K., & Melchior, L. M. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.08.035 · Cited by 5
Is high level of HbA1C an indicator for extended period of antibiotherapy in diabetic foot ulcers?
Doğan, M. (2018) · Northern Clinics of Istanbul · doi:10.14744/nci.2018.25582 · Cited by 5
Verdoia, M., Nardin, M., Negro, F., Rolla, R., Carriero, A., & Luca, G. D. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000786 · Cited by 5
Physical Activity Indicators, Metabolic Biomarkers, and Comorbidity in Type 2 Diabetes
Akıncı, B., Yeldan, İ., Çelik, S. G., & Satman, İ. (2019) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2019.1645269 · Cited by 6
Gong, L., Chang, S.-C., Wu, Q., Liu, Z., Wu, X., & Li, S. (2020) · Sleep And Breathing · doi:10.1007/s11325-020-02198-8 · Cited by 5
Jin, J., Cao, Y., Wu, L., You, X.-D., Guo, N., Guo, Y., Wu, N., Zhu, C., Xu, R., Liu, H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-037340 · Cited by 7
Wang, S., Lee, H. S., & Choi, W. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104598 · Cited by 5
Dong, Y., Chen, Z., Gong, Y., Han, Y., Yu, H., Zeng, X., Chen, Z., An, R., Sun, N., & Yin, X. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac485 · Cited by 5
Deng, Y., Liu, Y., Zhang, S., Yu, H., Zeng, X., An, R., Chen, Z., Sun, N., Yin, X., & Dong, Y. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13331 · Cited by 5
Fuentes, B. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.01.017 · Cited by 5
Ye, M., Zhang, J., Li, J., Liu, Y., He, W. W., Lin, H., Fan, R., Li, C., Li, W., Liu, D., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13055 · Cited by 5
Deprescribing Statins—Is It Ethical?
Strandberg, T. E. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14270 · Cited by 5
Mindil, A., Mohery, M., Kamel, M. S., Taya, Y. A., Mohamed, W. S., & Shokr, E. K. (2026) · Journal of Materials Science Materials in Electronics · doi:10.1007/s10854-025-16455-7 · Cited by 4
Khaleqsefat, E., Rasul, K. H., Kheder, R. K., Baban, S., & Baban, J. (2025) · Scientific Reports · doi:10.1038/s41598-024-75461-7 · Cited by 4
Santilli, F., Blaha, M. J., Ricci, F., & Simeone, P. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02966-4 · Cited by 8
Pappa, E. T., Kostara, C. E., Bairaktari, E. T., Arvaniti, E., & Tsimihodimos, V. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108286 · Cited by 4
Mandal, S., Belli, H. M., Cruz, J., Mann, D., & Schoenthaler, A. (2022) · JMIR Diabetes · doi:10.2196/41140 · Cited by 4
Cluster Enrollment: A Screening Tool for Stroke Risk Factors in Minority Women Caregivers
Ifejika, N. L., Bhadane, M. Y., Cai, C. C., Noser, E. A., & Savitz, S. I. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.10.013 · Cited by 4
Sarhadi, N. A., Fakhreddin-nejad, M.-E., Rajabi, M.-H., Mokarrari, S., Naghipour, E., Hooshmand, K., & Hashemi, M. M. (2019) · Journal of Clinical and Basic Research · doi:10.29252/jcbr.3.1.6 · Cited by 4
Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease
Misra, A., & Fisher, E. A. A. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.012 · Cited by 4
Mamudu, H. M., Jones, A., Paul, T. K., Osedeme, F., Stewart, D. W., Alamian, A., Wang, L., Orimaye, S. O., Bledsoe, J., Poole, A., et al. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107851 · Cited by 4
Khaliq, A., Chughtai, M. F. J., Javed Iqbal, M., Nawaz, H., Ahsan, S., Mehmood, T., Liaqat, A., Nadeem, M., Sameed, N., Saeed, K., et al. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_16 · Cited by 4
Paul, T. J., Mehawej, J., & Philis‐Tsimikas, A. (2021) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2021.09.005 · Cited by 4
de Beer, J. C., Snyman, J. S., Ker, J., Miller-Jansön, H., & Stander, M. (2022) · Value in Health Regional Issues · doi:10.1016/j.vhri.2022.08.012 · Cited by 4
Dobesh, P. P., & Patel, M. R. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6749-7 · Cited by 4
Self-citationÇelik, O. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.47587 · Cited by 4
Role of Glucose and Lipids in the Atherosclerotic Cardiovascular Disease of Patients with Diabetes
Feingold, K. R. (2020) · Europe PMC (PubMed Central) · Cited by 4
Oral, E. A. (2016) · Drugs in Context · doi:10.7573/dic.212299 · Cited by 6
Refining risk in diabetes and CAD with SPECT MPI: New insights and future challenges
Naqvi, S. Y., Wittlin, S. D., & Schwartz, R. G. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1177-4 · Cited by 4
Li, J., Ye, J., Zhou, Q., Guo, K., & Zhou, Z. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111942 · Cited by 3
Jadhav, V. B., Ahire, Y. S., Patil, C. D., & Vaghela, J. S. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00750 · Cited by 3
Preventing Cardiovascular Disease in Patients With Diabetes
Worel, J. N., & Hayman, L. L. (2016) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000333 · Cited by 3
Validación de un instrumento para medir la adherencia al tratamiento en hipertensión y diabetes
Guevara, S. L. R., Parra, D. I., Roa‐Díaz, Z. M., & Rojas, L. Z. (2020) · Revista CUIDARTE · doi:10.15649/cuidarte.1062 · Cited by 3
Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
Ahmad, B. A., Sanghani, I. M., Sayabugari, R., Biju, H., Siddegowda, A., Kinattingal, M. I., Yartha, S. G. R., Gaonkar, P. M., Andrabi, S. S., Vaghamashi, Y., et al. (2023) · Cureus · doi:10.7759/cureus.46373 · Cited by 3
Gourgari, E., Stafford, J. M., D'Agostino, R., Jr., Dolan, L. M., Lawrence, J. M., Mottl, A. K., Pihoker, C., Urbina, E. M., Wadwa, R. P., & Dabelea, D. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.187 · Cited by 3
Shah, T. (2020) · Interventional Cardiology · doi:10.37532/fmic.2020.12(1).643 · Cited by 3
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
Palma, C. C. S. S. V., Lopes, P. M., Silva, E. L. C., Bevilaqua, M. D. F. D. M., Bomfim, A. D. S., & Gomes, M. B. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s251780 · Cited by 3
Diabetes and the Cardiovascular System
Rigato, M., Fadini, G. P., & Avogaro, A. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_6-3 · Cited by 3
Kobalava, Z. D., & Kiyakbaev, G. (2018) · Kardiologiia · doi:10.18087/cardio.2018.1.10082 · Cited by 3
van Koeverden, I. D., Scholtes, V. P. W., den Ruijter, H. M., Hazenberg, S. C. E. V. B., de Kleijn, D. P. V., & de Borst, G. J. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.10.017 · Cited by 3
Zhou, Y.-G., Yin, R., Wu, J., Zhang, Q.-H., Chen, W., & Cao, X. (2018) · Europe PMC (PubMed Central) · Cited by 3
Effects of dapagliflozin on serum low-density lipoprotein cholesterol and triglyceride levels
Gürkan, E. (2020) · doi:10.5152/eurjther.2020.19005 · Cited by 3
Harishkaruppiah, R. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104983 · Cited by 2
Monnard, C. R., & Grasser, E. K. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02120-3 · Cited by 2
Islam, M., & Kabir, Y. (2022) · Frontiers in cardiovascular drug discovery · doi:10.2174/9789815036909122060007 · Cited by 2
Bonet, G., Carrasquer, A., Peiró, Ó. M., Sánchez-Giménez, R., Lal-Trehan, N., Del-Moral-Ronda, V., Fort-Gallifa, I., & Bardajı́, A. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02220-1 · Cited by 2
Al-Bayyari, N. S. (2017) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/4/3/00182 · Cited by 1
Cardiovascular disease risk reduction in diabetes through conventional and natural approaches
Schultz, W. M., Mahlof, E. N., Dhindsa, D. S., Varghese, T., Heinl, R. E., Cai, H. C., Sandesara, P. B., Eapen, D. J., & Sperling, L. S. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000134 · Cited by 3
He, T., Geng, J., & Zhang, Z. (2017) · Translational medicine research · doi:10.1007/978-981-10-5804-2_9 · Cited by 2
Цукровий діабет і мозковий інсульт: сучасний погляд на проблему
Pashkovska, N. V., & Pashkovskyy, V. M. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.4.2018.140181 · Cited by 2
Zolotukhina, Y. O. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.8.2018.154852 · Cited by 2
Reducing the Burden of Diabetes Mellitus in the State of Missouri: A Call to Action.
Drees, B. M., & Yun, S. (2016) · Europe PMC (PubMed Central) · Cited by 2
Rosa, R. C. D., & Romanelli, A. (2022) · Ain-Shams Journal of Anaesthesiology · doi:10.1186/s42077-021-00201-2 · Cited by 2
Medoff, B. S., Herbert, B. M., Baird, A. S., & Magnani, J. W. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100062 · Cited by 2
Too much TRAFfic at the crossroads of diabetes and endothelial dysfunction
Bagi, Z. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00614.2017 · Cited by 2
Arnold, M., Gill, D., & Mira, K. (2021) · Neurology · doi:10.1212/wnl.0000000000011557 · Cited by 2
Shmid, A., & Mkrtumyan, A. M. (2019) · Actual Problems of Systems and Software Engineering (APSSE) · doi:10.1109/apsse47353.2019.00025 · Cited by 1
Multilevel Longitudinal Functional Principal Component Model
Lin, W., Zou, J., Di, C., Rock, C. L., & Natarajan, L. (2024) · Statistics in Medicine · doi:10.1002/sim.10207 · Cited by 1
Lu, L., Gao, C., Wu, N., He, S., Liu, Y., Zhang, N., & Zhou, J. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005135 · Cited by 1
Park, D., Kim, K., Koh, H.-S., Han, K., & Choi, Y. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2025.143 · Cited by 1
Effects of community-based education on the risk factors in prediabetic older adults
Arana-Ramos, J. C., Brito-Zurita, O. R., Arana-Moreno, J. C., & Sabag-Ruíz, E. (2016) · Revista cubana de endocrinología · Cited by 1
Stuenkel, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_15 · Cited by 1
Metadata
- Authors
- Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., Inzucchi, S. E., Kosiborod, M., Nelson, R. G., Patel, M. J., Pignone, M., Quinn, L., Schauer, P. R., Selvin, E., & Vafiadis, D. K.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- Johns Hopkins University (US)
- University of California San Diego (US)
- Pennington Biomedical Research Center (US)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Office of Dietary Supplements (US)
- National Institutes of Health (US)
- Yale University (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Illinois Chicago (US)
- Cleveland Clinic (US)
- American Heart Association (US)
- ORCID
- Venue
- Circulation
- Published
- 2015-08-25
- Volume
- 132
- Issue
- 8
- Pages
- 691-718
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC9728095
- OpenAlex
- W2172043580
- Cited by
- 386
- References
- 262
- Citations by year
- 2026: 16 · 2025: 8 · 2024: 18 · 2023: 18 · 2022: 35 · 2021: 40 · 2020: 45 · 2019: 41 · 2018: 55 · 2017: 61 · 2016: 42 · 2015: 7
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (ZIADK069062, P30DK079637)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- type 2 diabetes, cardiovascular disease prevention, primary prevention, blood pressure control, glycemic control, cholesterol management, aspirin therapy, lifestyle modification, kidney disease screening, subclinical cardiovascular disease, clinical guidelines
- MeSH terms
- American Heart Association, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Primary Prevention, Risk Factors, United States, Randomized Controlled Trials as Topic, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
